EBRO 2017

FDG-PET in follow-up of larynx carcinoma

RELAPSE study

no recurrence n = 49

R a

laryngoscopy n = 72

n d o m i z a t i

recurrence n = 23

recurrence n = 1 no recurrence n = 30

n = 150

negative n = 31

PET n = 75

o n

recurrence n = 23 no recurrence n = 21

positive n = 44

50% less (futile) laryngoscopies

de Bree, Radiother. Oncol. 2016